What is APMD's current stock price?

APMD (Apnimed, Inc.) is currently trading at $25.71 with a market cap of $1.02B.

What sector is Apnimed, Inc. in?

Apnimed, Inc. (APMD) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

APMD Apnimed, Inc.

NASDAQHealthcare

$25.71+2.84%ClosedMarket Cap: $1.02B

As of 2026-08-04

Why APMD matters now

Apnimed, Inc. (APMD) is a US stock in Healthcare. The latest InvestLog snapshot shows $25.71 with +2.84% on the session and $1.02B in market capitalization.

The latest indexable market news headline is "Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares" from GlobeNewsWire.

Latest News

Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire · 2026-08-03

Sleep apnea pill developer Apnimed targets $608 million valuation in US IPOReuters · 2026-07-27

Apnimed Seeks IPO For OSA Treatment CommercializationSeeking Alpha · 2026-07-23

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.